$AMG

Issue of New Ordinary Shares & Total Voting Rights

Atlas Metals Group plc said it received a conversion notice from YA II PN Ltd (Yorkville Advisors) under its convertible loan. £86,780.82 of principal and accrued interest will convert into 1,112,574 new ordinary shares at 7.80p. Separately, 2,255,820 shares will be issued under an at-the-market facility at an average 8.795p. Admission of 3,368,394 shares is expected around 27 May 2026; total voting rights will be 42,549,821.

Original reporting
Published May 26, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 4:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Issue of New Ordinary Shares & Total Voting Rights — source image
Decision brief

The 30-second read

$AMGNeutralMed
01

Why it matters

Yorkville will convert £86,780.82 of principal plus accrued interest into 1,112,574 shares at 7.80p, and Atlas will issue 2,255,820 additional ATM shares at an average 8.795p; all ATM proceeds go toward repayment of the Funding Facility. LSE admission for 3,368,394 new shares is expected around 27 May 2026, after which total voting rights will be 42,549,821.

02

Market read

This is a capital-structure update with explicit dilution mechanics and a near-term admission date, making it relevant for short-term trading around expected share issuance.

03

What to watch

The conversion/ATM pricing (7.80p vs 8.795p) and the exact market reaction depend on the current share price and whether investors interpret this as supportive refinancing versus distressed funding.

Relevance 8/10Timing: Admission expected on or around 27 May 2026; dilution impact likely to be priced into shares before/around that date.

Background

Atlas Metals previously announced a convertible loan Funding Facility (5 March 2026) and an at-the-market (ATM) facility with Axis Capital Markets.

Company-level read

Ticker impact

$AMGNeutralMedium confidence
Context

Atlas Metals will issue 3.37M new shares via Yorkville conversion and its ATM facility, changing dilution and capital structure ahead of admission.

Expected impact

Likely near-term downside/volatility from dilution expectations, partially offset by the stated use of proceeds to repay the convertible facility.

Evidence & confidence

The filing is a routine capital-raise mechanics update, but it specifies conversion/ATM share quantities, pricing, and timing of LSE admission (~27 May 2026), which directly affects dilution and float.

Market effects

Signals ongoing reliance on convertible/ATM financing in small-cap natural resources, which can influence perceived funding risk across similar issuers.

UK-listed small-cap liquidity and order-book dynamics may react around LSE admission and increased share count.

Limited global spillover; impact is primarily on the issuer’s capital structure and UK trading venue mechanics.

Counterpoint

Because ATM proceeds are directed to repay the funding facility, the net effect could be viewed as reducing leverage/financing overhang rather than purely dilutive.

Key entities

  • Atlas Metals Group plc

    Company issuing new ordinary shares via convertible conversion and ATM facility; provides total voting rights denominator post-admission.

  • YA II PN Ltd (Yorkville Advisors Global, LP)

    Institutional investor converting part of the outstanding convertible loan into new ordinary shares.

  • Axis Capital Markets Limited

    Counterparty to the at-the-market facility used to issue additional ordinary shares.

  • London Stock Exchange plc

    Admission venue for the new shares to be admitted to trading on the main market.

Related articles

$AMGMed

AFFILIATED MANAGERS GROUP, INC. (AMG): Results of Operations and Financial Condition

AFFILIATED MANAGERS GROUP, INC. (AMG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amgq22026ex991.htm EX-99.1 Document Exhibit 99.1 Investor and Media Relations: Patricia Figueroa +1 (617) 747-3300 ir@amg.com pr@amg.com AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2026 Company reports Diluted EPS of $6.95, Econo

$AMGMedAI 8/10

AMG Critical Materials N.V.: AMG Increases Guidance Following an Exceptional Second Quarter 2026

AMG Critical Materials reported Q2 2026 adjusted EBITDA of $92 million, up 30% from $71 million in Q2 2025, helped by lithium and vanadium profitability and phasing effects. The company raised 2026 adjusted EBITDA guidance to $230 to $250 million. Liquidity was $508 million at June 30, 2026, and it closed the Zinnwald Lithium acquisition on July 27.

$AMGMedAI 8/10

AMG Critical Materials N.V. Successfully Closes the Acquisition of Zinnwald Lithium Plc.

AMG Critical Materials N.V. (Euronext Amsterdam: AMG) said it has completed its acquisition of the remaining ~71% stake in Zinnwald Lithium Plc, following terms announced May 14, 2026. Zinnwald shares are expected to convert into AMG shares and be credited to Zinnwald shareholders between July 29 and Aug 10, 2026. AMG plans a 18-24 month project review and advancement.

$AMGMed

AMG Critical Materials N.V. Completes Issuance of $700 Million New Credit Facilities

AMG Critical Materials N.V. (Euronext Amsterdam: AMG) said it closed $700 million of new credit facilities, including a $500 million 7-year senior secured term loan B and a $200 million 5-year senior secured revolving facility. The refinancing replaces $650 million existing facilities and extends maturities to 2033 and 2031. Moody’s, S&P, and Fitch assigned ratings to the new debt.

$AMGMed

Results of Court Meeting and General Meeting

Zinnwald Lithium plc said its court meeting and general meeting approved AMG Lithium B.V.’s recommended acquisition of the remaining Zinnwald shares via a UK Companies Act scheme. The required 75% votes were reached. Conditions 2(a) and 2(b) are satisfied, with a 23 July 2026 sanction hearing and expected completion on 27 July 2026.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.